» Articles » PMID: 26841785

Radionuclide Imaging Applications in Cardiomyopathies and Heart Failure

Overview
Publisher Current Science
Date 2016 Feb 5
PMID 26841785
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Multiple epidemiological factors including population aging and improved survival after acute coronary syndromes have contributed to a heart failure (HF) prevalence in the USA in epidemic proportions. In the absence of transplantation, HF remains a progressive disease with poor prognosis. The structural and functional abnormalities of the myocardium in HF can be assessed by various radionuclide imaging techniques. Radionuclide imaging may be uniquely suited to address several important clinical questions in HF such as identifying etiology and guiding the selection of patients for coronary revascularization. Newer approaches such as autonomic innervation imaging, phase analysis for synchrony assessment, and other molecular imaging techniques continue to expand the applications of radionuclide imaging in HF. In this manuscript, we review established and evolving applications of radionuclide imaging for the diagnosis, risk stratification, and management of HF.

Citing Articles

Computed tomography of cardiomyopathies.

Kalisz K, Rajiah P Cardiovasc Diagn Ther. 2017; 7(5):539-556.

PMID: 29255695 PMC: 5716950. DOI: 10.21037/cdt.2017.09.07.

References
1.
Merlet P, Benvenuti C, Moyse D, Pouillart F, Dubois-Rande J, DUVAL A . Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy. J Nucl Med. 1999; 40(6):917-23. View

2.
Beanlands R, Nichol G, Huszti E, Humen D, Racine N, Freeman M . F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2). J Am Coll Cardiol. 2007; 50(20):2002-12. DOI: 10.1016/j.jacc.2007.09.006. View

3.
Ohira H, Tsujino I, Ishimaru S, Oyama N, Takei T, Tsukamoto E . Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis. Eur J Nucl Med Mol Imaging. 2007; 35(5):933-41. DOI: 10.1007/s00259-007-0650-8. View

4.
Dilsizian V . Metabolic adaptation to myocardial ischemia: the role of fatty acid imaging. J Nucl Cardiol. 2007; 14(3 Suppl):S97-9. DOI: 10.1016/j.nuclcard.2007.02.008. View

5.
Lowes B, Gill E, Abraham W, Larrain J, Robertson A, Bristow M . Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure. Am J Cardiol. 1999; 83(8):1201-5. DOI: 10.1016/s0002-9149(99)00059-4. View